Welcome to our dedicated page for Applied UV news (Ticker: AUVI), a resource for investors and traders seeking the latest updates and insights on Applied UV stock.
Applied UV, Inc. (NASDAQ: AUVI), founded in 2012, is a pioneering company headquartered in Mount Vernon, New York. The company specializes in the design, manufacture, assembly, and distribution of automated disinfecting mirror systems, primarily for hospitals and healthcare facilities. They also create and supply custom-designed decorative framed mirrors, framed art, and bathroom vanities, catering mainly to the hospitality sector. Applied UV operates extensively across the United States and internationally.
The company's recent achievements include the launch of the Fighter Flex LED solution, which showcases advanced energy efficiency for HVAC systems. This technology, selected by the GSA and DOE for the Green Proving Ground Program, promises substantial energy savings by maintaining HVAC coil efficiency. The patented UVC LED system that Applied UV has developed can reduce energy consumption in HVAC systems by 5-15%, translating to approximately $45,000 in annual savings for a 100,000 square foot office space.
Applied UV is also making significant strides with its Smart Building Technologies division, which is expected to generate substantial revenue. With strategic investments and distribution agreements, the division anticipates a $10 million contribution from just three major accounts in 2024.
Expanding its horizon, Applied UV has engaged in a multi-year exclusive global licensing agreement with Element Designs to enhance outdoor systems for commercial and public spaces. This partnership will incorporate smart building technologies to further reduce energy consumption and enhance visual appeal.
The company’s disinfection technology, particularly the PURONet Control System, integrates continuous and terminal disinfection methods to ensure optimal cleanliness in healthcare settings. This innovative system is especially significant for operating rooms, providing a seamless switch between continuous low-level disinfection and deep terminal cleaning.
Moreover, Applied UV has entered the hospitality market with its plans for Larimar City & Resort in the Dominican Republic, expected to generate $250 million to $300 million over 3-6 years. This multi-use development will benefit from Applied UV’s custom interiors and smart energy-saving solutions.
In March 2024, the company announced a patent application for a disinfection system utilizing multiple wavelengths, enhancing its already robust portfolio of healthcare solutions. This system aims to optimize environmental cleanliness, particularly in healthcare facilities.
Overall, Applied UV continues to drive innovation and develop smart building technologies across healthcare, hospitality, commercial, and municipal markets.
Applied UV (NasdaqCM:AUVI) announced the engagement of Hayden IR for investor relations to enhance visibility and strengthen investment community relationships. Over the past year, Applied UV has completed several acquisitions to expand its surface and air disinfection offerings, aiming to meet increased demand. The company's product portfolio, which includes patented technologies like Airocide and Lumicide, targets infection control across various sectors. The collaboration with Hayden IR aims to effectively communicate Applied UV's business strategy and achievements to a broader audience.
Applied UV (NasdaqCM: AUVI) has received a significant order from the Tennessee Department of Correction for its Scientific Air S-400 UV-C pathogen-killing technology. This patented system will be implemented in prisons to combat COVID-19 and other pathogens, marking Applied UV's entry into the correctional facilities market. The S-400 boasts a 99.99%+ kill rate and is already in use across various healthcare facilities, addressing airborne infection control effectively. With 21,000 incarcerated individuals managed by TDOC, this represents a vital step in enhancing public health within correctional environments.
Applied UV (NasdaqCM: AUVI) announced a cash dividend of $0.21875 per share for its 10.5% Series A Cumulative Perpetual Preferred Stock, set to be paid on February 15, 2022, to shareholders recorded by February 4, 2022. The company specializes in pathogen elimination technology, leveraging UVC light and catalytic bioconversion for air purification. The announcement underscores Applied UV's commitment to providing shareholder returns while reinforcing its focus on infection control across diverse markets including healthcare and hospitality.
Applied UV (NASDAQ: AUVI) announced the granting of a patent in Hong Kong for its core SteriLumen pathogen-destroying device, expanding its intellectual property portfolio. This development is part of the company's strategy to combat the spread of pathogens through advanced air and surface sterilization technologies. Currently, Applied UV holds 62 patents in various jurisdictions for its disinfection products, which target markets like healthcare, hospitality, and food processing.
Applied UV (NASDAQ:AUVI, AUVIP) announced that underwriters exercised an over-allotment option to purchase an additional 400,000 shares of common stock, generating approximately $1.2 million in gross proceeds. This was part of a previously completed public offering of 2,666,667 shares priced at $3.00 per share. The offering's registration statement was declared effective on December 28, 2021, with a final prospectus filed shortly after. The funds raised will support Applied UV's focus on infection control technology in various markets.
Applied UV (NASDAQ: AUVI, AUVIP) has closed its underwritten public offering of 2,666,667 shares at $3.00 per share, generating approximately $8.0 million in gross proceeds. The company has also granted the underwriters a 45-day option to purchase up to an additional 400,000 shares to cover over-allotments. The proceeds will be used for general corporate purposes, including investments and acquisitions. The offering's registration was effective on December 28, 2021, and the final prospectus was filed on December 30, 2021.
Applied UV (NASDAQ:AUVI, AUVIP) has announced an underwritten public offering of 2,666,667 shares of common stock, priced at $3.00 per share, aiming to raise approximately $8.0 million before expenses. The offering is set to close around December 31, 2021, pending customary conditions. The net proceeds will support general corporate needs, including investments and acquisitions. Additionally, underwriters have a 45-day option to purchase an extra 400,000 shares for over-allotments. EF Hutton is the book-running manager for this offering.
Applied UV (NASDAQ:AUVI) has reviewed its operations and supply chain following recent acquisitions: Akida Holdings, Kes Science and Technology, and Scientific Air Management. The company will relocate its Denver operations to Atlanta, consolidating facilities to reduce costs and enhance synergies. Max Munn has been appointed as Interim CEO after the resignation of James Alecxih. John J. Hayman has been promoted to Interim COO, bringing 18 years of experience in the acquired company. The consolidation aims to streamline marketing and boost revenue through cross-selling diverse product lines.
Applied UV, Inc. (NASDAQ: AUVI) has announced a $0.21875 cash dividend for its 10.5% Series A Cumulative Perpetual Preferred Stock. This dividend will be paid on January 17, 2022, to shareholders on record by January 4, 2022. The company focuses on infection control technologies, utilizing narrow-range ultraviolet light and catalytic bioconversion technology for air purification. With products like Lumicide™ and Airocide®, Applied UV addresses critical health concerns in high-traffic environments.
Applied UV, Inc. (NASDAQ:AUVI) has appointed James Alecxih as its new CEO, effective December 8, 2021, following the resignation of Q Saeed, who will transition to a consulting role. Alecxih brings extensive experience in global sales and distribution of medical devices and healthcare technology. Under Saeed’s leadership, the company achieved a successful IPO and executed several key acquisitions in the disinfection space. The Board expressed confidence that Alecxih's expertise will be vital in driving growth and innovation in pathogen elimination technologies.
FAQ
What is the current stock price of Applied UV (AUVI)?
What is the market cap of Applied UV (AUVI)?
What does Applied UV, Inc. specialize in?
What is the Fighter Flex LED solution?
Where is Applied UV, Inc. headquartered?
What markets does Applied UV serve?
What recent partnerships has Applied UV entered into?
What is the PURONet Control System?
What is the significance of the Larimar City & Resort project?
How does Applied UV's UVC LED technology benefit HVAC systems?
What recent patent application did Applied UV file?
How is Applied UV contributing to energy efficiency?
